153 related articles for article (PubMed ID: 28761777)
1. Antimicrobial activities of widely consumed herbal teas, alone or in combination with antibiotics: an
Hacioglu M; Dosler S; Birteksoz Tan AS; Otuk G
PeerJ; 2017; 5():e3467. PubMed ID: 28761777
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
3. Determination of in vitro antidiabetic effects, antioxidant activities and phenol contents of some herbal teas.
Büyükbalci A; El SN
Plant Foods Hum Nutr; 2008 Mar; 63(1):27-33. PubMed ID: 18183488
[TBL] [Abstract][Full Text] [Related]
4. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
Ozseven AG; Sesli Çetin E; Ozseven L
Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.
Mataracı Kara E; Yılmaz M; Özbek Çelik B
J Glob Antimicrob Resist; 2019 Jun; 17():137-141. PubMed ID: 30576787
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Synergistic Effect of Tomatidine with Several Antibiotics against Standard and Clinical Isolates of
Soltani R; Fazeli H; Bahri Najafi R; Jelokhanian A
Iran J Pharm Res; 2017; 16(1):290-296. PubMed ID: 28496482
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
Dosler S; Gerceker AA
Chemotherapy; 2011; 57(6):511-6. PubMed ID: 22302084
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of distribution and drug resistance of pathogens of burn patients during 9 years].
Dou Y; Zhang Q
Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):153-159. PubMed ID: 29609277
[No Abstract] [Full Text] [Related]
11. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Turk Dagi H; Kus H; Arslan U; Tuncer I
Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interaction between ofloxacin and cefotaxime against common clinical pathogens.
Jenkins SG; Lewis JW
Infection; 1995; 23(3):154-61. PubMed ID: 7499004
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
14. Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
Hosgor-Limoncu M; Ermertcan S; Tasli H; Yurtman AN
West Indian Med J; 2008 Mar; 57(2):106-11. PubMed ID: 19565951
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of antimicrobial agents, alone and in combination, against Acinetobacter baumannii isolated from blood.
Chang SC; Chen YC; Luh KT; Hsieh WC
Diagn Microbiol Infect Dis; 1995 Nov; 23(3):105-110. PubMed ID: 8849654
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Synergy of
Su PA; Li SL; Tang HJ; Chen CC; Lu YC; Cheng KC; Lin YC; Chuang YC; Lai CC
Antibiotics (Basel); 2020 Feb; 9(3):. PubMed ID: 32121385
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.
Marques MB; Brookings ES; Moser SA; Sonke PB; Waites KB
Antimicrob Agents Chemother; 1997 May; 41(5):881-5. PubMed ID: 9145838
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of in vitro antibiotic synergy against Acinetobacter baumannii.
March GA; Bratos MA
J Microbiol Methods; 2015 Dec; 119():31-6. PubMed ID: 26415528
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
[TBL] [Abstract][Full Text] [Related]
20. In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms.
Dosler S; Mataraci E
Peptides; 2013 Nov; 49():53-8. PubMed ID: 23988790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]